Carotid Plaque Composition by Magnetic Resonance Imaging During Lipid Lowering Therapy

Trial Profile

Carotid Plaque Composition by Magnetic Resonance Imaging During Lipid Lowering Therapy

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Atorvastatin (Primary) ; Colesevelam (Primary) ; Niacin (Primary)
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2019.
    • 25 Jun 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Aug 2018.
    • 02 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top